Technology (IRT) – IXRS®3
Technology (IRT) – IXRS®3
Used in more than 2,800 clinical trials and in 120+ countries around the world
Over the past several years, clinical trials have become increasingly intricate. Study sponsors now aim to satisfy multiple objectives within a single, more complex protocol. As the level of complexity grows, it’s imperative that the technology employed to capture this critical data keeps up.
Almac Clinical Technologies has earned a reputation for providing a level of flexibility through Interactive Response Technology (IRT) software that is unmatched in the industry.
Available in multiple modalities, our market-leading solution for patient randomisation and trial supply management is the most configurable and customisable Interactive Response Technology available. From Phase I through to IV, simple designs to complex adaptive trials, IXRS®3 will easily accommodate any permutation of study objectives, and with it comes a team of professional biostatisticians, language and integration experts who are at the ready 24/7.
Clinical Trial Data Integration
Cost-effective and highly efficient strategies
Our clinical trial Data Services team is dedicated to creating strategies that can accommodate your needs quickly and methodically. They have extensive experience working with all formats necessary for data transfer and integrating with central laboratory systems, Clinical Trial Management Systems (CTMS), Drug Supply Management Systems (DSMS), leading Electronic Data Capture (EDC) software and other data analysis and management systems.
Through consultancy, our team works to identify relevant interactive web/voice response data to integrate with any target system. We support numerous file formats, transmission methods and frequency needs. Custom decodes of data are also supported, to allow for reduced coding and the easier processing of data.
As partners, we take pride in finding solutions for the various clinical trial data challenges you may face. With our vast experience, we can also advise you on implementation practices common to your industry peers and help you implement common software technologies - improving your overall operational readiness and ease of adoption.
We are proud members of CDISC, which establishes standards for the integration of clinical trial data from all sources.
Clinical Trial Reporting
All of your clinical trial data, where you need it to be
Today’s clinical trial managers need instant access to accurate data in order to make informed decisions that can impact timelines and costs. Empowering users with real-time reporting means sponsors and sites can quickly address compliance issues, adverse events and supply and patient needs.
IXRS®3 Reports is a powerful, user-friendly reporting system which helps clinicians and supply management professionals maximize the value of their clinical data. With standard and custom dashboards, IXRS®3 Reports can create client view alerts, clinical trial metrics, Key Performance Indicators (KPIs) and other clinical trial-related information available at a glance. Generating key study data from the IXRS® Interactive Response Technology database, we provide faster access for up-to-date clinical trial information.
With IXRS®3 Reports you also have the ability to view your data in real-time and drill down, sort, filter, analyze and share information quickly with other team members. You can easily create graphs, charts and tables to display information, as well as, custom reports that can be saved in the Cloud for future use.
IXRS®3 Reports online help tool features:
- An easy-to-use menu view of all reports contained in IXRS®3 Reports
- A quick index (content) search by keywords contained in the report
- A keyword search for all reports containing the query
IXRS®3 Reports can be accessed through multiple operating systems, including Apple Safari® , BlackBerry® software, Google ChromeTM, Internet Explorer® and Firefox®. Reports can also be exported to a variety of formats.
IXRS® is a registered trademark of Almac Clinical Technologies, LLC. All other trademarks are the property of their respective owners.
As part of our commitment to innovation and providing a better IRT experience for clinical trial operations, we’ve partnered with Exostar to bring industry-leading Single Sign-On (SSO) capabilities to users of the IXRS®3 platform. This technological advance enables Almac IRT users to seamlessly utilize their pre-existing network account credentials in order to log in to the IXRS – eliminating the need to manage and maintain another set of single-usage credentials.
This capability not only increases site productivity and security for Trial Sponsor entities, Contract Research Organizations (CROs), cloud application providers, and other participating members, but also reduces the impact to patients waiting to be treated as well.
Increased site productivity
- Reduced cognitive load of using single-usage user name and password combinations
- Reduced number of calls to the help desk
Reduced impacts to patient
- Less time fumbling with passwords, more time with patient
- Less chance of having to send a patient home and reschedule a crucial visit because of lockout issues
- Eliminate the need to have printouts of user names and passwords
- Makes consistent use of good password practices easier
By the numbers
- 510 studies lasting 5+ years
- 115 studies lasting 4+ years
- 44 studies with over 500 sites
- 170 studies with 200 sites
- 55 studies with more than 5,000 patients
- 34 trials with 10,000+ patients